InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,127.79
(
1.26%
)
US TECH 100
17,446.00
(
2.17%
)
Dow Jones
38,675.68
(
1.18%
)
Brent Oil
83.30
(
0.20%
)
Bitcoin
64,185.84
(
0.29%
)
Post# of 7992
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

ottoman

Send PM Follow Ignore
Followers 59
Posts 17802
Boards Moderated 1
Alias Born 03/17/2004

ottoman

Re: None

Tuesday, 06/27/2017 8:23:47 AM

Tuesday, June 27, 2017 8:23:47 AM

Post# of 7992
Morning gents/gals. watching XENE and TEVA bioturds. XENE currently halted. Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) and Xenon Pharmaceuticals Inc. (Nasdaq: XENE) announce top-line results in a Phase II study of topical TV-45070 in patients with post-herpetic neuralgia (PHN). TV-45070 did not meet the primary endpoint of a statistically significant change in pain from baseline to week four as assessed by the numeric rating scale (NRS).

http://ih.advfn.com/p.php?pid=nmona&article=75120128

============================================================


Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up